Frank P. McCormick's most recent trade in BridgeBio Pharma Inc was a trade of 74,000 Common Stock done at an average price of $53.2 . Disclosure was reported to the exchange on Sept. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BridgeBio Pharma Inc | Frank P. McCormick | Director | Sale of securities on an exchange or to another person at price $ 53.16 per share. | 05 Sep 2025 | 74,000 | 83,275 (0%) | 0% | 53.2 | 3,933,544 | Common Stock |
| BridgeBio Pharma Inc | Frank P. McCormick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.92 per share. | 05 Sep 2025 | 74,000 | 157,275 (0%) | 0% | 11.9 | 882,080 | Common Stock |
| BridgeBio Pharma Inc | Frank P. McCormick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2025 | 74,000 | 84,814 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Oncology | Frank P. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 91,076 | 91,076 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Frank P. McCormick | Director | Sale of securities on an exchange or to another person at price $ 44.23 per share. | 24 Jun 2025 | 100,000 | 879,979 (0%) | 0% | 44.2 | 4,422,800 | Common Stock |
| BridgeBio Pharma Inc | Frank P. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 8,425 | 8,425 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Frank P. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 6,589 | 83 (0%) | 0% | 0 | Common Stock | |
| BridgeBio Pharma Inc | Frank P. McCormick | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 May 2025 | 33,000 | 79,686 (0%) | 0% | 0 | Common Stock | |
| BridgeBio Pharma Inc | Frank P. McCormick | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 May 2025 | 3,000 | 76,686 (0%) | 0% | 0 | Common Stock | |
| BridgeBio Pharma Inc | Frank P. McCormick | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Dec 2024 | 7,400 | 464,976 (0%) | 0% | 0 | Common Stock | |
| BridgeBio Pharma Inc | Frank P. McCormick | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Dec 2024 | 7,400 | 112,686 (0%) | 0% | 0 | Common Stock | |
| BridgeBio Pharma Inc | Frank P. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 26,014 | 26,014 | - | - | Stock Option (Right to Buy) |